Search research articles
Contact Us
Filters
Showing results (81-90 of 321) with videos related to
Page
of 33
Sort By:
British Journal of Cancer
|
November 1, 1996
A phase II study of tamoxifen plus melatonin in metastatic solid tumour patients
P Lissoni, F Paolorossi, G Tancini, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1993
Neuroimmunotherapy of advanced solid neoplasms with single evening subcutaneous injection of low-dose interleukin-2 and melatonin: preliminary results
P Lissoni, S Barni, F Rovelli, et al.
Journal of Biological Regulators and Homeostatic Agents
|
December 20, 2007
Cancer chemotherapy-induced lymphocytosis: a revolutionary discovery in the medical oncology
P Lissoni, L Fumagalli, F Brivio, et al.
Hepato-Gastroenterology
|
December 2, 2000
Surgery-induced decline in circulating dendritic cells in operable cancer patients: a possible explanation of postoperative immunosuppression
F Brivio, R Gilardi, R Bucocev, et al.
Minerva Chirurgica
|
April 15, 1993
Influence of blood transfusions on surgery-induced immune changes in colorectal carcinoma
F Brivio, P Lissoni, R Redaelli, et al.
Journal of Biological Regulators and Homeostatic Agents
|
January 1, 1995
Immune effects of preoperative immunotherapy with high-dose subcutaneous interleukin-2 versus neuroimmunotherapy with low-dose interleukin-2 plus the neurohormone melatonin in gastrointestinal tract tumor patients
P Lissoni, F Brivio, O Brivio, et al.
Oncology
|
January 1, 1992
Effects of a preoperative therapy with interleukin-2 on surgery-induced lymphocytopenia in cancer patients
F Brivio, P Lissoni, E Tisi, et al.
Journal of Biological Regulators and Homeostatic Agents
|
October 1, 1993
Cancer immunotherapy with low-dose interleukin-2 subcutaneous administration: potential efficacy in most solid tumor histotypes by a concomitant treatment with the pineal hormone melatonin
P Lissoni, S Barni, A Ardizzoia, et al.
Oncology
|
May 1, 1995
A randomized study of low-dose subcutaneous interleukin-2 plus melatonin versus supportive care alone in metastatic colorectal cancer patients progressing under 5-fluorouracil and folates
S Barni, P Lissoni, M Cazzaniga, et al.
Oncology
|
January 1, 1990
Pineal gland and tumor cell kinetics: serum levels of melatonin in relation to Ki-67 labeling rate in breast cancer
P Lissoni, S Crispino, S Barni, et al.
Page
of 33
Search research articles
Search
Showing results (81-90 of 321) with videos related to
Sort By:
Page
of 33
British Journal of Cancer
|
November 1, 1996
A phase II study of tamoxifen plus melatonin in metastatic solid tumour patients
P Lissoni, F Paolorossi, G Tancini, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1993
Neuroimmunotherapy of advanced solid neoplasms with single evening subcutaneous injection of low-dose interleukin-2 and melatonin: preliminary results
P Lissoni, S Barni, F Rovelli, et al.
Journal of Biological Regulators and Homeostatic Agents
|
December 20, 2007
Cancer chemotherapy-induced lymphocytosis: a revolutionary discovery in the medical oncology
P Lissoni, L Fumagalli, F Brivio, et al.
Hepato-Gastroenterology
|
December 2, 2000
Surgery-induced decline in circulating dendritic cells in operable cancer patients: a possible explanation of postoperative immunosuppression
F Brivio, R Gilardi, R Bucocev, et al.
Minerva Chirurgica
|
April 15, 1993
Influence of blood transfusions on surgery-induced immune changes in colorectal carcinoma
F Brivio, P Lissoni, R Redaelli, et al.
Journal of Biological Regulators and Homeostatic Agents
|
January 1, 1995
Immune effects of preoperative immunotherapy with high-dose subcutaneous interleukin-2 versus neuroimmunotherapy with low-dose interleukin-2 plus the neurohormone melatonin in gastrointestinal tract tumor patients
P Lissoni, F Brivio, O Brivio, et al.
Oncology
|
January 1, 1992
Effects of a preoperative therapy with interleukin-2 on surgery-induced lymphocytopenia in cancer patients
F Brivio, P Lissoni, E Tisi, et al.
Journal of Biological Regulators and Homeostatic Agents
|
October 1, 1993
Cancer immunotherapy with low-dose interleukin-2 subcutaneous administration: potential efficacy in most solid tumor histotypes by a concomitant treatment with the pineal hormone melatonin
P Lissoni, S Barni, A Ardizzoia, et al.
Oncology
|
May 1, 1995
A randomized study of low-dose subcutaneous interleukin-2 plus melatonin versus supportive care alone in metastatic colorectal cancer patients progressing under 5-fluorouracil and folates
S Barni, P Lissoni, M Cazzaniga, et al.
Oncology
|
January 1, 1990
Pineal gland and tumor cell kinetics: serum levels of melatonin in relation to Ki-67 labeling rate in breast cancer
P Lissoni, S Crispino, S Barni, et al.
Page
of 33